This information is our interpretation of CPT coding requirements and may not necessarily be correct
doi: 10.3390/metabo11080531 Summary Keywords dysbiosis, gutbrain axis, healthcare, incretin therapy, microbial metabolites Citation Cadena-Ullauri S, Cadena Paredes AS, Guamn-Herrera L, Imbaquingo-Espinales J, Ruiz-Pozo VA, Tamayo-Trujillo R, Guevara-Ramrez P, Paz-Cruz E and Zambrano AK (2026) Tirzepatide and the gut microbiotaobesity axis: metabolic mechanisms and therapeutic perspectives
Staging of brain pathology related to sporadic Parkinsons disease
LLY stock has been under some pressure lately, tracking its third consecutive weekly decline
The Medicare GLP-1 Bridge covers all formulations of Foundayo
Breathing difficulties are typically related to underlying conditions like obesity, cardiovascular disease, or sleep apnea rather than tirzepatide itself